News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
8,139 Results
Type
Article (404)
Company Profile (11)
Press Release (7724)
Section
Business (1803)
Deals (291)
Drug Delivery (2)
Drug Development (1876)
FDA (198)
Job Trends (363)
News (3965)
Policy (308)
Tag
2027 Biotech Bay Standard (1)
Academia (26)
Alliances (450)
ALS (8)
Alzheimer's disease (4)
Antibody-drug conjugate (ADC) (11)
Approvals (211)
Artificial intelligence (9)
Autoimmune disease (10)
Automation (1)
Best Places to Work (379)
Biotechnology (11)
Bladder cancer (17)
Brain cancer (4)
Breast cancer (31)
Cancer (248)
Cardiovascular disease (12)
CAR-T (23)
Cell therapy (67)
Cervical cancer (2)
Clinical research (1656)
Collaboration (42)
Compensation (4)
COVID-19 (9)
CRISPR (16)
C-suite (19)
Cystic fibrosis (4)
Data (227)
Depression (2)
Diabetes (7)
Diagnostics (57)
Drug discovery (2)
Drug pricing (2)
Duchenne muscular dystrophy (3)
Earnings (775)
Events (1682)
Executive appointments (18)
FDA (287)
Funding (38)
Gene editing (41)
Gene therapy (46)
GLP-1 (6)
Government (52)
Guidances (2)
Healthcare (276)
HIV (3)
Huntington's disease (3)
IgA nephropathy (1)
Immunology and inflammation (3)
Immuno-oncology (1)
Indications (7)
Infectious disease (10)
Inflammatory bowel disease (1)
Intellectual property (7)
IPO (204)
IRA (1)
Job creations (8)
Layoffs (8)
Legal (22)
Liver cancer (9)
Lung cancer (34)
Lymphoma (24)
Machine learning (4)
Manufacturing (16)
Medical device (33)
Medtech (33)
Mergers & acquisitions (98)
Metabolic disorders (7)
Multiple sclerosis (3)
Neurodegenerative disease (5)
Neuropsychiatric disorders (2)
Neuroscience (28)
NextGen: Class of 2026 (75)
Non-profit (41)
Opinion (5)
Ovarian cancer (7)
Pain (1)
Pancreatic cancer (12)
Parkinson's disease (5)
Partnered (2)
Patents (10)
Patient recruitment (18)
People (638)
Phase 1 (720)
Phase 2 (747)
Phase 3 (482)
Pipeline (142)
Policy (2)
Postmarket research (13)
Preclinical (219)
Press Release (1)
Prostate cancer (24)
Psychedelics (3)
Radiopharmaceuticals (6)
Rare diseases (40)
Real estate (21)
Regulatory (347)
Research institute (27)
Series A (6)
Series B (3)
Service/supplier (1)
Sickle cell disease (20)
Spinal muscular atrophy (5)
Startups (46)
Supply chain (1)
Vaccines (6)
Venture capital (1)
Women's health (1)
Date
Today (1)
Last 7 days (14)
Last 30 days (39)
Last 365 days (691)
2026 (58)
2025 (702)
2024 (842)
2023 (970)
2022 (1053)
2021 (1083)
2020 (782)
2019 (518)
2018 (356)
2017 (304)
2016 (298)
2015 (275)
2014 (195)
2013 (133)
2012 (133)
2011 (100)
2010 (57)
Location
Africa (3)
Alaska (1)
Arizona (1)
Asia (357)
Australia (46)
California (265)
Canada (66)
China (27)
Colorado (3)
Connecticut (4)
Delaware (21)
Europe (1449)
Florida (29)
Georgia (2)
Illinois (7)
India (2)
Indiana (1)
Japan (14)
Louisiana (1)
Maryland (32)
Massachusetts (252)
Minnesota (7)
Missouri (2)
Nevada (1)
New Hampshire (1)
New Jersey (83)
New York (44)
North Carolina (44)
Northern California (187)
Ohio (5)
Pennsylvania (77)
South America (2)
South Carolina (1)
Southern California (32)
Texas (48)
United States (935)
Utah (2)
Virginia (4)
Washington State (19)
Wisconsin (5)
8,139 Results for "curative".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Aspect Biosystems and Novo Nordisk enter new phase of partnership to develop curative medicines for diabetes
January 20, 2026
·
4 min read
Press Releases
Century Therapeutics Secures Oversubscribed $135 Million Private Placement Financing to Support Lead Program, CNTY-813, a Potentially Curative Therapy for Type 1 Diabetes
January 8, 2026
·
7 min read
Press Releases
Trogenix announces £70 million / $95 million Series A financing to drive clinical development of potentially curative therapies for aggressive cancers
October 6, 2025
·
6 min read
Press Releases
Brii Biosciences Presents Late-Breaking Data from Ongoing Phase 2 ENSURE Study at AASLD 2025, Reinforcing BRII-179’s Potential as a Curative Treatment for Chronic Hepatitis B
November 11, 2025
·
6 min read
Opinion
Automated Manufacturing Will Meet CAR T Demand
Next-generation automation is closing the gap between curative science and real-world demand, enabling faster development, global consistency and broader patient access to CAR T therapies.
January 6, 2026
·
3 min read
·
Ossama Eissa
Press Releases
CAR T Vision Coalition Launches with Ambitious Goal to Double Patients Treated with the Curative Potential of CAR T-cell Therapy by 2030
May 30, 2025
·
5 min read
Curative Biotechnology, Inc. Announces Nomination of Dr. Theresa Heah to Board of Directors.
Curative Biotechnology Inc. (OTC: CUBT) (“Curative Biotech” or the “Company”), a development-stage biomedical company focused on novel treatments for degenerative eye diseases today announced the nomination to its Board of Directors of Dr. Theresa Heah.
January 8, 2024
·
4 min read
Business
Curative Appoints Brandon Charles as New Chief Medical Officer
Dr. Brandon Charles has joined Curative as its new Chief Medical Officer.
November 28, 2023
·
3 min read
Business
Curative Biotechnology, Inc. Announces Nomination of Dr. Jeffrey Liebmann to Board of Directors
Curative Biotechnology Inc. today announced its nomination to its Board of Directors of Dr. Jeffrey Liebmann.
October 31, 2023
·
4 min read
Autoimmune disease
Sanofi Joins With EVOQ in $500M Autoimmune Alliance
The partners have yet to disclose what their priority indications are, though EVOQ’s NanoDisc technology aims to enable the development of potentially curative treatments for autoimmune conditions such as celiac disease and type 1 diabetes.
October 16, 2025
·
2 min read
·
Tristan Manalac
1 of 814
Next
